Gene expression profiling of TNBC and OVCA cell lines in response to Azacitidine and Talazoparib
Ontology highlight
ABSTRACT: Triple negative breast cancer and ovarian cancer cell lines were treated with Azacitidine, Talazoparib, or combination for a period of 10 days to assess global transcriptional response. The focus of these transcriptional studies were on the assessment of DNA repair and immune pathway alteration by the therapeutics under study with the aim of defining novel inducers of BRCAness.
ORGANISM(S): Homo sapiens
PROVIDER: GSE150298 | GEO | 2020/05/20
REPOSITORIES: GEO
ACCESS DATA